Global Cell Isolation Market 2019-2023

細胞分離の世界市場2019-2023

◆タイトル:Global Cell Isolation Market 2019-2023
◆商品コード:IRTNTR31324
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年5月16日
◆ページ数:130
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、細胞分離の世界市場について調査・分析し、市場概要、市場環境、細胞分離市場規模、製品別(消耗品、器具)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・細胞分離の世界市場概要
・細胞分離の世界市場環境
・細胞分離の世界市場動向
・細胞分離の世界市場規模
・細胞分離の世界市場:業界構造分析
・細胞分離の世界市場:製品別(消耗品、器具)
・細胞分離の世界市場:地域別市場規模・分析
・細胞分離の北米市場規模・予測
・細胞分離のヨーロッパ・中東・アフリカ市場規模・予測
・細胞分離のアジア太平洋市場規模・予測
・細胞分離の主要国分析
・細胞分離の世界市場:意思決定フレームワーク
・細胞分離の世界市場:成長要因、課題
・細胞分離の世界市場:競争環境
・細胞分離の世界市場:関連企業情報(ベンダー分析)

About this market

The rise in demand for clinical diagnosis is one of the key factors anticipated to drive the cell isolation market growth during the forecast period. To effectively treat various diseases using genetic engineering tools, early diagnosis is essential. Genetic engineering tools provide diagnostic enzymes such as cholesterol oxidase and xylitol oxidase. These diagnostic enzymes identify specific cells like cells with high levels of cholesterol. When blood levels of these particular enzymes increase significantly, it indicates a probable site for tissue damage, which releases these enzymes in the blood. These enzymes are used in assays using samples of serum or urine. The isolation of these enzymes can provide the required enzymes for clinical diagnosis. Thus, genetic engineering tools are useful, precise, and economical for researchers and healthcare providers to diagnose patients. Technavio’s analysts have predicted that the cell isolation market will register a CAGR of almost 19% by 2023.

Market Overview
Increasing prevalence of chronic diseases

The growing incidences of chronic diseases have increased the need for cell-based therapies. Cell isolation is an important step in various experiments during diagnostics and research of chronic diseases. Cell isolation tools are increasingly used in drug discovery techniques to generate recombinant protein therapeutics, which can treat a variety of diseases, including cancer, autoimmune diseases, and genetic disorders. The wide applications of isolated human cells in research, drug development, and clinical trials are increasing with growing incidences of chronic diseases globally. Hence, the rising prevalence of chronic diseases increases the demand for cell-based therapies, which increases the demand for cell isolation tools.

Ethical issues regarding embryonic stem cell isolation

The high potential of stem cell-based therapy in clinical applications has encouraged researchers to use stem cell tools to treat genetic disorders in pharmacy genomics and regenerative medicines. However, clinical applications of stem cells raise some ethical and safety concerns regarding the extraction of human embryonic stem cells. The key issue lies with the destruction of a human embryo, which impedes the development of human embryonic stem cell-based clinical therapies.

For the detailed list of factors that will drive and challenge the growth of the cell isolation market during 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly fragmented. The presence of several companies, including Agilent Technologies Inc. and Becton Dickinson and Co., makes the competitive environment quite intense. Several vendors are expected to participate in such strategic alliances to gain a competitive advantage, which will improve the availability of cell isolation products in the market. Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Consumables – Market size and forecast 2018-2023

Instruments – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

Market segmentation by end-user

Comparison by end-user

AR – Market size and forecast 2018-2023

PB – Market size and forecast 2018-2023

CRO – Market size and forecast 2018-2023

Others – Market size and forecast 2018-2023

Market opportunity by end-user

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

Product advances

Growing adoption of genetic engineering in forensic research

Strategic alliances

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Agilent Technologies Inc.

Becton Dickinson and Co.

Merck KGaA

QIAGEN NV

Thermo Fisher Scientific Inc.

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global healthcare market

Exhibit 02: Segments of global healthcare market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Product – Market share 2018-2023 (%)

Exhibit 18: Comparison by product

Exhibit 19: Consumables – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Consumables – Year-over-year growth 2019-2023 (%)

Exhibit 21: Instruments – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Instruments – Year-over-year growth 2019-2023 (%)

Exhibit 23: Market opportunity by product

Exhibit 24: Customer landscape

Exhibit 25: End-user – Market share 2018-2023 (%)

Exhibit 26: Comparison by end-user

Exhibit 27: AR – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: AR – Year-over-year growth 2019-2023 (%)

Exhibit 29: PB – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: PB – Year-over-year growth 2019-2023 (%)

Exhibit 31: CRO – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: CRO – Year-over-year growth 2019-2023 (%)

Exhibit 33: Others – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Others – Year-over-year growth 2019-2023 (%)

Exhibit 35: Market opportunity by end-user

Exhibit 36: Market share by geography 2018-2023 (%)

Exhibit 37: Geographic comparison

Exhibit 38: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: North America – Year-over-year growth 2019-2023 (%)

Exhibit 40: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 41: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 42: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 43: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 44: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 45: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 46: Key leading countries

Exhibit 47: Market opportunity

Exhibit 48: Impact of drivers and challenges

Exhibit 49: Vendor landscape

Exhibit 50: Landscape disruption

Exhibit 51: Vendors covered

Exhibit 52: Vendor classification

Exhibit 53: Market positioning of vendors

Exhibit 54: Agilent Technologies Inc. – Vendor overview

Exhibit 55: Agilent Technologies Inc. – Business segments

Exhibit 56: Agilent Technologies Inc. – Organizational developments

Exhibit 57: Agilent Technologies Inc. – Geographic focus

Exhibit 58: Agilent Technologies Inc. – Segment focus

Exhibit 59: Agilent Technologies Inc. – Key offerings

Exhibit 60: Becton Dickinson and Co. – Vendor overview

Exhibit 61: Becton Dickinson and Co. – Business segments

Exhibit 62: Becton Dickinson and Co. – Organizational developments

Exhibit 63: Becton Dickinson and Co. – Geographic focus

Exhibit 64: Becton Dickinson and Co. – Segment focus

Exhibit 65: Becton Dickinson and Co. – Key offerings

Exhibit 66: Merck KGaA – Vendor overview

Exhibit 67: Merck KGaA – Business segments

Exhibit 68: Merck KGaA – Organizational developments

Exhibit 69: Merck KGaA – Geographic focus

Exhibit 70: Merck KGaA – Segment focus

Exhibit 71: Merck KGaA – Key offerings

Exhibit 72: QIAGEN NV – Vendor overview

Exhibit 73: QIAGEN NV – Product segments

Exhibit 74: QIAGEN NV – Organizational developments

Exhibit 75: QIAGEN NV – Geographic focus

Exhibit 76: QIAGEN NV – Segment focus

Exhibit 77: QIAGEN NV – Key offerings

Exhibit 78: Thermo Fisher Scientific Inc. – Vendor overview

Exhibit 79: Thermo Fisher Scientific Inc. – Product segments

Exhibit 80: Thermo Fisher Scientific Inc. – Organizational developments

Exhibit 81: Thermo Fisher Scientific Inc. – Geographic focus

Exhibit 82: Thermo Fisher Scientific Inc. – Segment focus

Exhibit 83: Thermo Fisher Scientific Inc. – Key offerings

Exhibit 84: Validation techniques employed for market sizing

Exhibit 85: Definition of market positioning of vendors



【掲載企業】

Agilent Technologies Inc.、Becton Dickinson and Co.、Merck KGaA、QIAGEN NV、Thermo Fisher Scientific Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[細胞分離の世界市場2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆